Jeffrey V. Poulton - Net Worth and Insider Trading
Jeffrey V. Poulton Net Worth
The estimated net worth of Jeffrey V. Poulton is at least $3 Million dollars as of 2024-04-29. Jeffrey V. Poulton is the EVP, CFO of Alnylam Pharmaceuticals Inc and owns about 19,535 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $3 Million. Details can be seen in Jeffrey V. Poulton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey V. Poulton has not made any transactions after 2024-02-28 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey V. Poulton
Jeffrey V. Poulton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey V. Poulton owns 3 companies in total, including Homology Medicines Inc (FIXX) , Alnylam Pharmaceuticals Inc (ALNY) , and CervoMed Inc (CRVO) .
Click here to see the complete history of Jeffrey V. Poulton’s form 4 insider trades.
Insider Ownership Summary of Jeffrey V. Poulton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FIXX | Homology Medicines Inc | 2020-07-21 | director |
| ALNY | Alnylam Pharmaceuticals Inc | 2024-02-28 | Chief Financial Officer |
| CRVO | CervoMed Inc | 2023-08-16 | director |
Jeffrey V. Poulton Latest Holdings Summary
Jeffrey V. Poulton currently owns a total of 1 stock. Jeffrey V. Poulton owns 19,535 shares of Alnylam Pharmaceuticals Inc (ALNY) as of February 28, 2024, with a value of $3 Million.
Latest Holdings of Jeffrey V. Poulton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2024-02-28 | 19,535 | 143.31 | 2,799,561 |
Holding Weightings of Jeffrey V. Poulton
Jeffrey V. Poulton Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey V. Poulton has made a total of 3 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 574 shares on February 28, 2024, which brought Jeffrey V. Poulton around $89,142.
Insider Trading History of Jeffrey V. Poulton
- 1
Jeffrey V. Poulton Trading Performance
Jeffrey V. Poulton Ownership Network
Ownership Network List of Jeffrey V. Poulton
Ownership Network Relation of Jeffrey V. Poulton
Jeffrey V. Poulton Owned Company Details
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Jeffrey V. Poulton is the director of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Jeffrey V. Poulton made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
Jeffrey V. Poulton Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey V. Poulton. You might contact Jeffrey V. Poulton via mailing address: 300 Third Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
